Children born following IVF, ovulation induction may face higher pediatric cancer risk

Mothers who undergo fertility treatments may give birth to children who are at a heightened risk for developing pediatric tumors and cancers, according to study published in the American Journal of Obstetrics & Gynecology.

Advertisement

Israeli researchers conducted a population-based cohort analysis of 242,187 babies born between 1991 and 2013. Of the babies, 237,863 were conceived spontaneously; 2,603 were conceived after in vitro fertilization, and 1,721 were conceived after ovulation induction treatments. The follow-up period was approximately 10.6 years.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

The study shows that in all, providers diagnosed 1,498 tumors, indicating a variety of cancers such as leukemia, brain and spinal cord tumors, neuroblastomas, Wilms tumors and Hodgkin and non-Hodgkin lymphoma.

The incidence rate for tumors was highest among children either after IVF (1.5/1000), and slightly lower for OI births (1.0/1000). Naturally conceived children had a low tumor incidence rate (.59/1000).

More articles on healthcare quality:
Experts: US needs more comprehensive MRSA tracking system
7 things to know about inpatient, outpatient antibiotic use
FDA approves diagnostic tool for antibiotic stewardship

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.